Transport at Nanoscale Interfaces Laboratory

February 28, 2018

New start-up company  MOMM Diagnostics GmbH founded.

MOMM Diagnostics GmbH, an R&D oriented startup in life sciences focusing on medical diagnostics, was established in Basel, Switzerland in February 2018. Our activities focus on the development of a novel in-vitro diagnostic device for the early diagnosis of preeclampsia (PE) at the point-of-care (POC)implementing a novel readout technology which allows an increased signal to noise ratio at a smaller form factor and lower cost. MOMM Diagnostics will develop a device for rapid PE testing consisting of single-use cartridges for the simultaneous analysis of multiple PE biomarkers from patient’s blood in conjunction with a hand-held reader for immediate use at POC.

Further information:

Dr. Mathias Wipf

CEO MOMM Diagnostics & Transport at Nanoscale Interfaces Laboratory
Phone +41 58 765 4611
mathias.wipf@empa.ch